Researchers Submit Patent Application, "ANTIVIRAL STRUCTURALLY-STABILIZED SARS-CoV-2 PEPTIDES AND USES THEREOF", for Approval (USPTO 20240124529).
In: Medical Letter on the CDC & FDA, 2024-05-10, S. 3746-3746
serialPeriodical
Zugriff:
A patent application has been submitted for the invention of antiviral peptides that can potentially treat and prevent coronavirus infections, including COVID-19. These peptides are designed to strengthen the structure of certain proteins, making them resistant to degradation and capable of inhibiting viral fusion and infection. The application provides detailed information on the amino acid sequences and properties of these peptides. These structurally-stabilized polypeptides have the potential to be effective against SARS-CoV-2, the virus that causes COVID-19. [Extracted from the article]
Copyright of Medical Letter on the CDC & FDA is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Researchers Submit Patent Application, "ANTIVIRAL STRUCTURALLY-STABILIZED SARS-CoV-2 PEPTIDES AND USES THEREOF", for Approval (USPTO 20240124529).
|
---|---|
Zeitschrift: | Medical Letter on the CDC & FDA, 2024-05-10, S. 3746-3746 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1532-4648 (print) |
Schlagwort: |
|
Sonstiges: |
|